Haemonetics Corporation (HAE) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-27..
Quick ratio
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-27. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 263.24M USD | Liabilities, Current |
| Cash and equivalents | 223.38M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 216.07M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 306.74M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-27 | (m) | $263.24M | $223.38M | (m) | $216.07M | $306.74M | (m) |
| 2026-03-28 | (m) | $282.60M | $245.44M | (m) | $216.85M | $306.37M | (m) |
| 2025-12-27 | (m) | $539.87M | $363.37M | (m) | $195.71M | $321.19M | (m) |
| 2025-09-27 | (m) | $548.32M | $296.43M | (m) | $207.07M | $336.21M | (m) |
| 2025-06-28 | (m) | $531.41M | $292.90M | (m) | $200.75M | $360.53M | (m) |
| 2025-03-29 | (m) | $578.11M | $306.76M | (m) | $202.66M | $365.14M | (m) |
| 2024-12-28 | (m) | $253.23M | $320.85M | (m) | $211.95M | $359.61M | (m) |
| 2024-09-28 | (m) | $273.95M | $299.28M | (m) | $213.53M | $382.11M | (m) |
| 2024-06-29 | (m) | $260.08M | $344.43M | (m) | $201.49M | $373.79M | (m) |
| 2024-03-30 | (m) | $300.38M | $178.80M | (m) | $206.56M | $317.20M | (m) |
| 2023-12-30 | (m) | $261.75M | $193.98M | (m) | $211.61M | $304.02M | (m) |
| 2023-09-30 | (m) | $264.21M | $351.00M | (m) | $174.25M | $285.83M | (m) |
| 2023-07-01 | (m) | $236.94M | $285.72M | (m) | $177.12M | $289.21M | (m) |
| 2023-04-01 | (m) | $251.82M | $284.47M | (m) | $179.14M | $259.38M | (m) |
| 2022-12-31 | (m) | $226.89M | $224.00M | (m) | $181.10M | $255.76M | (m) |
| 2022-10-01 | (m) | $262.18M | $241.20M | (m) | $171.53M | $254.68M | (m) |
| 2022-07-02 | (m) | $180.49M | $214.95M | (m) | $146.46M | $277.89M | (m) |
| 2022-04-02 | (m) | $442.27M | $259.50M | (m) | $159.38M | $293.03M | (m) |
| 2022-01-01 | (m) | $355.41M | $236.88M | (m) | $154.98M | $305.74M | (m) |
| 2021-10-02 | (m) | $288.47M | $192.42M | (m) | $141.31M | $322.66M | (m) |
| 2021-07-03 | (m) | $228.34M | $173.46M | (m) | $132.91M | $326.50M | (m) |
| 2021-04-03 | (m) | $253.50M | $192.31M | (m) | $127.56M | $322.61M | (m) |
| 2020-12-26 | (m) | $194.38M | $189.00M | (m) | $146.94M | $299.71M | (m) |
| 2020-09-26 | (m) | $338.57M | $279.17M | (m) | $141.53M | $305.22M | (m) |
| 2020-06-27 | (m) | $407.83M | $275.73M | (m) | $141.09M | $294.51M | (m) |
| 2020-03-28 | (m) | $274.82M | $137.31M | (m) | $165.21M | $270.28M | (m) |
| 2019-12-28 | (m) | $256.69M | $126.42M | (m) | $170.75M | $254.17M | (m) |
| 2019-09-28 | (m) | $240.07M | $112.03M | (m) | $176.53M | $244.50M | (m) |
| 2019-06-29 | (m) | $293.67M | $190.23M | (m) | $163.34M | $221.95M | (m) |
| 2019-03-30 | (m) | $235.76M | $169.35M | (m) | $185.03M | $194.34M | (m) |
| 2018-12-29 | (m) | $211.28M | $154.87M | (m) | $167.64M | $168.94M | (m) |
| 2018-09-29 | (m) | $189.17M | $199.76M | (m) | $161.59M | $163.58M | (m) |
| 2018-06-30 | (m) | $194.00M | $192.11M | (m) | $151.34M | $175.33M | (m) |
| 2018-03-31 | (m) | $384.70M | $180.17M | (m) | $151.23M | $160.80M | (m) |
| 2017-12-30 | (m) | $324.18M | $251.59M | (m) | $146.72M | $158.84M | (m) |
| 2017-09-30 | (m) | $255.00M | $203.62M | (m) | $143.69M | $168.59M | (m) |
| 2017-07-01 | (m) | $205.52M | $171.74M | (m) | $151.51M | $173.89M | (m) |
| 2017-04-01 | (m) | $211.18M | $139.56M | (m) | $152.68M | $176.93M | (m) |
| 2016-12-31 | (m) | $216.22M | $129.64M | (m) | $150.56M | $188.49M | (m) |
| 2016-10-01 | (m) | $198.66M | $138.87M | (m) | $151.60M | $194.51M | (m) |
| 2016-07-02 | (m) | $198.97M | $118.25M | (m) | $149.67M | $189.43M | (m) |
| 2016-04-02 | (m) | $185.55M | $115.12M | (m) | $157.09M | $187.03M | (m) |
| 2015-12-26 | (m) | $175.33M | $105.17M | (m) | $148.77M | $203.86M | (m) |
| 2015-09-26 | (m) | $188.10M | $100.25M | (m) | $145.41M | $207.65M | (m) |
| 2015-06-27 | (m) | $169.76M | $112.20M | (m) | $139.10M | $211.13M | (m) |
| 2015-03-28 | (m) | $189.09M | $160.66M | (m) | $145.83M | $211.08M | (m) |
| 2014-12-27 | (m) | $164.34M | $125.20M | (m) | $143.63M | $212.49M | (m) |
| 2014-09-27 | (m) | $165.06M | $129.97M | (m) | $151.06M | $209.42M | (m) |
| 2014-06-28 | (m) | $165.87M | $139.94M | (m) | $156.73M | $207.49M | (m) |
| 2014-03-29 | (m) | $216.93M | $192.47M | (m) | $164.60M | $197.66M | (m) |
| 2013-12-28 | (m) | $189.01M | $177.85M | (m) | $149.59M | $209.33M | (m) |
| 2013-09-28 | (m) | $198.19M | $159.15M | (m) | $162.08M | $205.25M | (m) |
| 2013-06-29 | (m) | $187.79M | $166.33M | (m) | $155.96M | $196.67M | (m) |
| 2013-03-30 | (m) | $180.14M | $179.12M | (m) | $170.11M | $183.78M | (m) |
| 2012-12-29 | (m) | $177.61M | $193.18M | (m) | $167.35M | $180.04M | (m) |
| 2012-09-29 | (m) | $156.19M | $187.05M | (m) | $158.18M | $173.51M | (m) |
| 2012-06-30 | (m) | $121.91M | $236.05M | (m) | $126.13M | $126.84M | (m) |
| 2012-03-31 | (m) | $130.74M | $228.86M | (m) | $135.46M | $117.16M | (m) |
| 2011-12-31 | (m) | $109.37M | $205.37M | (m) | $127.44M | $107.91M | (m) |
| 2011-10-01 | (m) | $110.81M | $183.42M | (m) | $129.24M | $101.44M | (m) |
| 2011-07-02 | (m) | $103.02M | $216.89M | (m) | $120.76M | $94.96M | (m) |
| 2011-04-02 | (m) | $108.67M | $196.71M | (m) | $127.17M | $84.39M | (m) |
| 2011-01-01 | (m) | $105.53M | $169.54M | (m) | $120.37M | $81.92M | (m) |
| 2010-10-02 | (m) | $113.75M | $115.05M | (m) | $121.77M | $86.01M | (m) |
| 2010-07-03 | (m) | $102.01M | $83.47M | (m) | $114.83M | $84.57M | (m) |
| 2010-04-03 | (m) | $136.50M | $141.56M | (m) | $118.68M | $79.95M | (m) |
| 2009-12-26 | (m) | (m) | $168.99M | (m) | (m) | (m) | (m) |
| 2009-09-26 | (m) | (m) | $178.32M | (m) | (m) | (m) | (m) |
| 2009-06-27 | (m) | (m) | $173.82M | (m) | (m) | (m) | (m) |
| 2009-03-28 | (m) | (m) | $156.72M | (m) | (m) | (m) | (m) |
| 2008-03-29 | (m) | (m) | $133.55M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |